Photo: Bloomberg
Photo: Bloomberg

FIR against Snapdeal in Maharashtra for selling prescription drugs online

An FDA team had raided Snapdeal's premises in Goregaon on 17 April

Mumbai: The food and drug administration (FDA) of Maharashtra government has decided to book online retailer Snapdeal’s CEO Kunal Bahal and other directors on charges of selling prescription drugs through the web site without a permit and doctor’s prescription.

“Under the Drugs and Cosmetics Act 1940, the sale of prescription drugs by unlicenced vendors is an offence and if found guilty can attract rigorous imprisonment from three to five years," FDA commissioner Harshdeep Kamble said.

An FDA team had raided Snapdeal’s premises in Goregaon on 17 April and seized prescription drugs like Ascoril (cough syrup) and Vigora (for impotence) along with delivery challans to customers, copies of agreements with vendors to sell the drugs through the portal.

Kamble had then said the FDA was trying to find the volume of business transacted and further action would depend on the outcome of the probe.

“Earlier this week we concluded our investigation and decided to register an FIR (first information report) against the company," he said. “We are also examining dealings of a few other online retail portals to find out whether they have indulged in similar practices and we hope to conclude our investigations by next week."

Snapdeal in a statement on Friday said sellers list such products despite the company periodically telling them to engage in fair and safe sales. “Upon being notified of any such products, we delist the products and take appropriate action against such seller," the company said in a statement.

The company will continue to assist FDA team in its probe. “We have already delisted the products, informed sellers and also stopped payment, in addition to providing all information to the FDA team as required by them," the statement said.

Close